Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Cancer Research|July 7, 2026
Targeting Cystine Addiction Suppresses Breast Cancer Lung MetastasisJosep Tarragó-Celada, Asad S Mahmood, Yulia Panina, et al.Wellcome Open Research|June 8, 2021
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assayMichael D Buck, Enzo Z Poirier, Ana Cardoso, et al.Science Advances|April 23, 2021
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
SARS-CoV-2 recruits a haem metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.Science (New York, N.Y.)|April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunityEvangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.Nature Biotechnology|July 19, 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.Pageof 9